Pfizer Inc. (PFE)
28.46
+0.50
(+1.81%)
USD |
NYSE |
Aug 31, 16:00
28.53
+0.06
(+0.23%)
After-Hours: 20:00
Pfizer Cash from Operations (Annual) : 11.70B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 11.70B |
| December 31, 2024 | 12.74B |
| December 31, 2023 | 8.70B |
| December 31, 2022 | 33.23B |
| December 31, 2021 | 32.58B |
| December 31, 2020 | 14.40B |
| December 31, 2019 | 12.59B |
| December 31, 2018 | 15.83B |
| December 31, 2017 | 16.80B |
| December 31, 2016 | 15.90B |
| December 31, 2015 | 14.69B |
| December 31, 2014 | 16.88B |
| December 31, 2013 | 17.76B |
| December 31, 2012 | 16.75B |
| December 31, 2011 | 20.24B |
| December 31, 2010 | 11.45B |
| December 31, 2009 | 16.59B |
| December 31, 2008 | 18.24B |
| December 31, 2007 | 13.35B |
| December 31, 2006 | 17.59B |
| December 31, 2005 | 14.73B |
| December 31, 2004 | 16.34B |
| Date | Value |
|---|---|
| December 31, 2003 | 11.72B |
| December 31, 2002 | 10.18B |
| December 31, 2001 | 9.291B |
| December 31, 2000 | 6.195B |
| December 31, 1999 | 3.076B |
| December 31, 1998 | 2.925B |
| December 31, 1997 | 1.629B |
| December 31, 1996 | 2.067B |
| December 31, 1995 | 1.821B |
| December 31, 1994 | 1.488B |
| December 31, 1993 | 1.263B |
| December 31, 1992 | 807.00M |
| December 31, 1991 | 847.60M |
| December 31, 1990 | 860.50M |
| December 31, 1989 | 655.80M |
| December 31, 1988 | 872.60M |
| December 31, 1987 | 771.10M |
| December 31, 1986 | 732.10M |
| December 31, 1985 | 626.20M |
| December 31, 1984 | 724.30M |
| December 31, 1983 | 649.80M |
| December 31, 1982 | 599.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Johnson & Johnson | 24.53B |
| Eli Lilly & Co. | 16.81B |
| Merck & Co., Inc. | 16.47B |
| Bristol Myers Squibb Co. | 14.16B |
| Viatris, Inc. | 2.316B |